Fundz

Tell Bio reported raising $1.2 Million in an initial SEC Form D filing, from an offering of $1.2 Million

PRIVATEJul 08, 2024

Amount Raised

$1.2 Million

$1.2 Million sold, per SEC Form D (first sale Jun 21, 2024)

Round Type

Venture

BeverlyBiotechnology

Quick answer

TellBio raised $1.2 Million in a funding round, dated June 21, 2024. TellBio is based in Beverly, Massachusetts, United States.

How much did TellBio raise?
TellBio raised $1.2 Million in a funding round on June 21, 2024.
What does TellBio do?
TellBio, Inc is a development stage biotechnology company based in Beverly, Massachusetts, with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells..
Where is TellBio based and how big is it?
TellBio is based in Beverly, Massachusetts, United States.
Who are the decision-makers at TellBio?
Fundz holds 1 contact at TellBio, including the SVP, Head of Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as TellBio that raised within 45 days of this round, from Fundz verified event records.

Who to call at TellBio, and when

A new round usually means TellBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TellBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TellBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TellBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TellBio

Location

19 CONNECTOR RD

Beverly, Massachusetts, United States

About

TellBio, Inc is a development stage biotechnology company based in Beverly, Massachusetts, with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutic platform, TellDx and TellRx, respectively. The foundation of the Company’s approach – detection of and targeting CTCs – is exclusively licensed from Massachusetts General Hospital and is based on decades of academic and clinical research. TellBio’s vision is to free patients and their families from the tyranny of cancer via both its TellDx and TellRx platforms.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TellBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAnnie P., SVP, Head of OperationsSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TellBio's next move

See what Strategic adds

TellBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.